Andersen-Tawil syndrome screening: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
[[File:Holter monitor tracing.jpg|alt=Holter monitor tracing|center|thumb|745x745px|Holter monitor tracing demonstrating an episode of nonsustained bidirectional ventricular tachycardia. Case courtesy by Michael David Fryer et al<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750129/|title=Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>]] | [[File:Holter monitor tracing.jpg|alt=Holter monitor tracing|center|thumb|745x745px|Holter monitor tracing demonstrating an episode of nonsustained bidirectional ventricular tachycardia. Case courtesy by Michael David Fryer et al<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750129/|title=Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>]] | ||
[[File:A 12 lead ECG.jpg|alt=12 lead ECG|center|thumb|750x750px|A 12 lead ECG recorded from the patient showing frequent polymorphic ectopy. Case courtesy by Michael David Fryer et al<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750129/|title=Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>]] | |||
<br /> | <br /> | ||
==References== | ==References== | ||
Revision as of 14:39, 12 February 2020
|
Andersen-Tawil syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Andersen-Tawil syndrome screening On the Web |
|
American Roentgen Ray Society Images of Andersen-Tawil syndrome screening |
|
Risk calculators and risk factors for Andersen-Tawil syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
Screening
- There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
- But when a patient with positive KCNJ2 mutation and have no symptoms in Andersen-Tawil syndrome yearly screening with the following should be considered:
References
- ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K; et al. (1993). "GeneReviews®". PMID 20301441.
- ↑ Spillane, J; Kullmann, D M; Hanna, M G (2015). "Genetic neurological channelopathies: molecular genetics and clinical phenotypes". Journal of Neurology, Neurosurgery & Psychiatry: jnnp-2015–311233. doi:10.1136/jnnp-2015-311233. ISSN 0022-3050.
- ↑ Fernlund E, Lundin C, Hertervig E, Kongstad O, Alders M, Platonov P (2013). "Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome". Ann Noninvasive Electrocardiol. 18 (5): 471–8. doi:10.1111/anec.12074. PMID 24047492.
- ↑ "Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?".
- ↑ "Recurrent syncope in the Andersen Tawil syndrome – Cardiac or neurological?".